When in doubt over picking which stocks to own it's wise to look at what the experts are saying. Here are the 8 stocks with the highest percentage of buy ratings among analysts on Wall Street today.
Reuters calls it a "modern-day gold rush for drug makers". But how much money can this medical breakthrough make? Barclays Bank predicts it will grow into a $200 billion market. Making the upside potential of one drug maker as high as 42,000%. See the proof here
SAN JOSE, Calif. (AP) — A Silicon Valley executive who lied to investors about inventing technology that tested for allergies and COVID-19 using only a few drops of blood was sentenced Wednesday to eight years in prison and ordered to pay $24 million in restitution, federal prosecutors said. Continue Reading ➔
Jeff Bezos has bought a seven-bedroom mansion in Florida. The area is referred to as the 'Billionaire Bunker' due to its wealthy inhabitants. Continue Reading ➔
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all. Get the full story
Advanced Micro Devices, Inc (NASDAQ: AMD) stock is trading higher Monday in line with the broader index Invesco QQQ Trust, Series 1 (NASDAQ: QQQ) despite reports of the U.S. Continue Reading ➔
Some of America's best "Doomsday" investors are buying one stock right now...and on October 31st , you'll understand why. This stock has a track record of holding its own during bloodbaths. Get the ticker symbol
Kevin McCarthy dismissed speculation of his early resignation from Congress before his term ends in 2025 after being ousted from speakership. Continue Reading ➔
"Hi, I'm Teeka Tiwari...I'm about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk's new AI project... What happens next will shock you..." See what happened
Ming-Chi Kuo, a renowned tech analyst, reports a potential delay in the mass production of Apple's AirTag 2 until 2025, sparking discussions on the future and enhancements of AirTag technology amidst concerns of misuse for stalking. Continue Reading ➔
Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their stock price from the war. Continue Reading ➔
Meghan McCain, a Columbia University alumnus, has publicly denounced her alma mater over their handling of the conflict between Israel and Hamas, as reported by the Continue Reading ➔
Donald Trump and Joe Biden could find themselves facing off once again in the 2024 presidential election in a rematch of the 2020 presidential election, which saw Biden emerge victoriously. Continue Reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
